BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1976524)

  • 21. Effect of neonatal sympathectomy on development of angiotensin II-induced hypertension.
    Csiky B; Simon G
    Am J Physiol; 1997 Feb; 272(2 Pt 2):H648-56. PubMed ID: 9124421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of noradrenaline, B-HT 920, methoxamine, angiotensin II and vasopressin on mean circulatory filling pressure in conscious rats.
    Pang CC; Tabrizchi R
    Br J Pharmacol; 1986 Oct; 89(2):389-94. PubMed ID: 2877700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced in vivo responsiveness of presynaptic angiotensin II receptor-mediated facilitation of vascular adrenergic neurotransmission in spontaneously hypertensive rats.
    Cline WH
    J Pharmacol Exp Ther; 1985 Mar; 232(3):661-9. PubMed ID: 2983066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neural and humoral mechanisms of angiotensin-dependent hypertension.
    Cox BF; Bishop VS
    Am J Physiol; 1991 Oct; 261(4 Pt 2):H1284-91. PubMed ID: 1681742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-dependent changes in autonomic control of splanchnic vascular resistance and heart rate in ANG II-salt hypertension.
    Kuroki MT; Guzman PA; Fink GD; Osborn JW
    Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H763-9. PubMed ID: 22114134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lateral parabrachial nucleus and angiotensin II-induced hypertension.
    Fink GD; Pawloski CM; Ohman LE; Haywood JR
    Hypertension; 1991 Jun; 17(6 Pt 2):1177-84. PubMed ID: 1675203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of sympathetic and AT-receptor blockade on angiotensin II and adrenergic agonist-induced renal vasoconstrictions in spontaneously hypertensive rats.
    Abdulla MH; Sattar MA; Khan MA; Abdullah NA; Johns EJ
    Acta Physiol (Oxf); 2009 Mar; 195(3):397-404. PubMed ID: 19183357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of vasopressin and the sympathetic nervous system in the early phase of high sodium one-kidney renal hypertension.
    Hinojosa C; Haywood JR
    Hypertension; 1984; 6(6 Pt 1):848-54. PubMed ID: 6240442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased sympathetic activity in rats submitted to chronic intermittent hypoxia.
    Zoccal DB; Bonagamba LG; Oliveira FR; Antunes-Rodrigues J; Machado BH
    Exp Physiol; 2007 Jan; 92(1):79-85. PubMed ID: 17085676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pressor and renal vasoconstrictor effects of NG-nitro-L-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids and vasopressin.
    Pucci ML; Lin L; Nasjletti A
    J Pharmacol Exp Ther; 1992 Apr; 261(1):240-5. PubMed ID: 1560371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the anti-vasoconstrictor activity of BRL 34915 in spontaneously hypertensive rats; a comparison with nifedipine.
    Buckingham RE
    Br J Pharmacol; 1988 Mar; 93(3):541-52. PubMed ID: 3370388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ganglionic action of angiotensin contributes to sympathetic activity in renin-angiotensinogen transgenic mice.
    Ma X; Sigmund CD; Hingtgen SD; Tian X; Davisson RL; Abboud FM; Chapleau MW
    Hypertension; 2004 Feb; 43(2):312-6. PubMed ID: 14699002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats.
    Bayorh MH; Zukowska-Grojec Z; Kopin IJ; Feuerstein G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):85-90. PubMed ID: 6491978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II induces catecholamine release by direct ganglionic excitation.
    Dendorfer A; Thornagel A; Raasch W; Grisk O; Tempel K; Dominiak P
    Hypertension; 2002 Sep; 40(3):348-54. PubMed ID: 12215478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex differences in the development of angiotensin II-induced hypertension in conscious mice.
    Xue B; Pamidimukkala J; Hay M
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2177-84. PubMed ID: 15626687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II modulates conducted vasoconstriction to norepinephrine and local electrical stimulation in rat mesenteric arterioles.
    Gustafsson F; Holstein-Rathlou NH
    Cardiovasc Res; 1999 Oct; 44(1):176-84. PubMed ID: 10615401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracisternally applied angiotensin II does not excite reticulospinal vasomotor neurons in anesthetized rats.
    Sun MK; Reis DJ
    Eur J Pharmacol; 1996 May; 304(1-3):63-71. PubMed ID: 8813585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noradrenergic mechanisms in the brain and peripheral organs of normotensive and spontaneously hypertensive rats at various ages.
    Patel KP; Kline RL; Mercer PF
    Hypertension; 1981; 3(6):682-90. PubMed ID: 6117514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pressor sensitivities to vasopressin, angiotensin II, or methoxamine in diabetic rats.
    Hebden RA; Bennett T; Gardiner SM
    Am J Physiol; 1987 Nov; 253(5 Pt 2):R726-34. PubMed ID: 3318506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of losartan and carvedilol on vasopressor responses to adrenergic agonists and angiotensin II in the systemic circulation of Sprague Dawley rats.
    Abdulla MH; Sattar MA; Abdullah NA; Khan MA; Anand Swarup KR; Johns EJ
    Auton Autacoid Pharmacol; 2011; 31(1-2):13-20. PubMed ID: 21166975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.